Related Experiment Video
Updated: Feb 12, 2026
07:33
A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
Published on: May 21, 2010
37.3K
[Cerebellar Ataxia and Autoantibodies]
Kazunori Nanri1, Nobuaki Yoshikura, Akio Kimura
1Tokyo Medical University Hachioji Medical Center, Department of Neurology, Tokyo Medical University Hachioji Medical Center.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|April 11, 2018
Summary
Autoimmune cerebellar ataxia affects the cerebellum, a key central nervous system target. Early diagnosis and treatment, including immunotherapy and trigger removal, are crucial for managing this condition.
Area of Science:
- Neuroscience
- Immunology
- Neurology
Background:
- The cerebellum is a primary target for central nervous system autoimmunity.
- Immune-mediated cerebellar ataxias encompass conditions like gluten ataxia, GAD antibody-associated ataxia, Hashimoto's encephalopathy, and paraneoplastic cerebellar degeneration.
- Autoimmune cerebellar ataxia can present with insidious or subacute onset, sometimes preceded by vertigo or transient neurological symptoms, distinguishing it from spinocerebellar degeneration.
Purpose of the Study:
- To highlight the importance of early diagnosis and treatment for autoimmune cerebellar ataxia.
- To outline diagnostic methods for identifying autoimmune cerebellar ataxia.
- To discuss therapeutic strategies for managing autoimmune cerebellar ataxia.
Main Methods:
- Diagnostic testing includes assays for gliadin antibody, TG6 antibody, GAD antibody, thyroid antibody, and anti-neuronal antibodies (e.g., mGluR1).
- Magnetic resonance imaging (MRI) voxel-based morphometry aids in detecting cortical cerebellar atrophy characteristic of autoimmune cerebellar ataxia, differentiating it from spinocerebellar ataxia.
- Treatment involves identifying and removing autoimmune triggers, such as dietary gluten or neoplasms.
Main Results:
- Specific antibodies and MRI findings can aid in the diagnosis of autoimmune cerebellar ataxia.
- Identifying and removing triggers like gluten or neoplasms is a key treatment strategy.
- Immunotherapy, including intravenous immunoglobulin (IVIg) and steroid therapy, is considered for significant ataxia symptoms.
Conclusions:
- Autoimmune cerebellar ataxia requires prompt diagnosis and intervention.
- A combination of serological testing, neuroimaging, and trigger identification is essential for effective management.
- Treatment strategies should address both the autoimmune process and symptom management through immunotherapy when necessary.
